Key financial ranges
Market cap · USD equivalent−∞—+∞
P/E ratio−∞—+∞
Annual revenue · USD equivalent−∞—+∞
Revenue growth−∞—+∞
2,121–2,140 of 6,553
CompanyMarket capP/ERevenueRev. growthNet incomeCashDebtAI value
VIRVir Biotechnology, Inc.$1.94B—$68.56M-7.6%-$437.99M$278.73M$93.27MFair valued
IMCRImmunocore Holdings plc$1.93B—$400.02M+29.0%-$35.51M$484.92M$40.75MFair valued
PRLBProto Labs Inc$1.93B64.4×$533.13M+6.4%$21.24M$127.92M$2.24MOvervalued
WRDWeRide Inc.$1.93B—CN¥361.13M-10.1%-CN¥2.52BCN¥3.84BCN¥205.39MOvervalued
ZDZiff Davis, Inc.$1.93B—$1.45B+3.5%$47.35M$1.61B$867.64MUndervalued
DEIDouglas Emmett Inc$1.93B—$1B+1.8%$16.27M$354.96M$5.73BUndervalued
BLBlackline, Inc.$1.93B59.2×$700.43M+7.2%$24.52M$242.9M$690.74MUndervalued
HEHawaiian Electric Industries Inc$1.92B8.6×$3.08B-3.3%$126.28M$238.73M$2.8BFair valued
PDFSPdf Solutions Inc$1.92B180.2×$219.02M+22.0%-$640K$114.88M$71.56MOvervalued
ATSATS Corp$1.92B58.0×CA$2.53B-16.5%-CA$27.98MCA$225.95MCA$1.67BFair valued
LKFTLakefront Biotherapeutics NV$1.92B2.7×€1.11B+303.5%€320.88M€87.87M€6.92MUndervalued
OCFCOceanfirst Financial Corp$1.92B22.9×$404.92M+5.4%$70.98M$274.06M$2.36BUndervalued
STOKStoke Therapeutics, Inc.$1.91B—$184.42M+404.5%-$6.89M$110M$2.68MFair valued
MRVIMaravai Lifesciences Holdings, Inc.$1.91B—$185.74M-28.3%-$130.77M$70.09M$176.7MOvervalued
KRPKimbell Royalty Partners, LP$1.91B20.9×$333.83M+7.9%$99.65M$44.93M$4.57MUndervalued
GHRSGH Research PLC$1.9B————$246.25M$500KFair valued
FLOCFlowco Holdings Inc.$1.9B24.9×$341.76M+32.2%$41.4M$19.19M$342.14MUndervalued
EPACEnerpac Tool Group Corp$1.9B21.0×$616.9M+4.6%$92.75M$115.68M$184.79MFair valued
FLNCFluence Energy, Inc.$1.9B—$2.26B-16.1%-$48.31M$339.33M$21MFair valued
NLSTNetlist Inc$1.9B—$188.63M+28.2%-$24.82M$30.66M$1.29MOvervalued